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Abstract 
 The  time  required  to  initiate  clinical  trials,  from 
declaration of the investigator’s intent to opening of 
the  study  for  participant  accrual,  is  cited  as  often 
being  so  long  that  clinical  research  is  seriously 
impeded.  Efforts to improve operational efficiency of 
trial  initiation  are  confounded  by  the  work  flow 
complexity  and  the  variations  encountered  with 
different  types  of  trials  and  institutional 
environments.    A  computer  Protocol  Lifecycle 
Tracking  (PLT)  tool  would  enable  study  initiation 
staff to manage the process, and the various clinical 
research stakeholders to monitor the progress of a 
study’s initiation, as well as obtain data on the work 
flow to identify those activities  that are in need of 
operational efficiency improvement.   The objective 
of  our  work  was  to  develop  use  cases  and  system 
requirements for a PLT tool.  The result of our study 
is  a  use  case  document  that  can  serve  as  the 
specifications for developing  a PLT application.  
Introduction 
A  2005  report  on  restructuring  the  cancer  clinical 
trials  enterprise  stipulated  the  reduction  of 
operational  barriers  to  trial  initiation  among  its 
primary  goals.
1  Supporting  the  significance  of  trial 
initiation delay, Dilts and his colleagues, who have 
uniquely studied these processes involved in opening 
trials, concluded that in some situations “The steps 
required to develop and activate a clinical trial may 
require  as  much  or  more  time  than  the  actual 
completion of a trial.”
2  Another Dilts study, which  
evaluated  the  trial  initiation  processes  at  a  major 
academic  medical  center,  noted  that  while 
administrative  barriers  to  opening  trials  is  often 
criticized by researchers, the process has in general 
not been formally documented or evaluated.
3   
The  sometimes  long  delays  in  activating  clinical 
trials, as well as the conflicting anecdotal attributions 
for these delays, are well known to those involved in 
clinical  trials  research.    Correspondingly, 
comprehensive means for monitoring the work flow 
of  study  initiation  by  the  various  stakeholders  – 
principal  investigators,  clinical  research  associates, 
administrators – are not available. To address this, we 
have  undertaken  the  development  of  use  cases  and 
system  requirements  for  a  computer  Protocol 
Lifecycle  Tracking  tool,  which  would  not  only 
provide the capability to  manage the process flow 
and  monitor  the  progress  of  trial  initiation  in  real 
time, but also deconstruct the complex work flow and 
provide institution and study-type specific data on the 
contributing factors to initiation delays. 
Background 
The  National  Cancer  Institute’s  cancer  Biomedical 
Informatics Grid (caBIG
®) program, begun in 2004, 
includes clinical trials research informatics among its 
primary  domains  for  investigation.    The  caBIG
® 
Clinical  Trials  Management  System  (CTMS)  work 
space  has  created  a  Business  Architecture  Model 
(BAM) of the clinical trials research work flow, from 
study  initiation,  through  study  conduct,  to  study 
closure.
4  The  BAM  describes  the  activities,  goals, 
people, and organizational needs involved in clinical 
trials.  The almost 400 pages of use cases developed 
for  the  BAM  informed  CTMS  participants  of  the 
variability and complexity of  the clinical trials work 
flow:  the activities involved in planning, initiating, 
and conducting trials varies according to the sponsor 
(industry, government agency, cooperative group, or 
institutional  investigator  initiated)  and  whether  the 
sponsor (e.g., cooperative group) or performance site 
(e.g., cancer center) perspective is being considered;  
whether  the  trial  is  interventional  or  non-
interventional;  and  the  specifics  of  the  trial  itself 
(e.g., pharmaceuticals or device involved?).   
With  this  comprehensive  BAM  to  draw  upon,  we 
decided to develop the use cases and requirements for 
a  Protocol  Lifecycle  Tracking  computer  tool  that 
could  accommodate  the  inherently  variable  work 
flow of initiating clinical trials research.  So while the 
caBIG
® BAM describes the clinical trial processes, 
this PLT use case project describes the requirements 
for  a  tool  which  can  manage  these  processes.  
Furthermore, while this study arose from the caBIG
® 
program,  non-oncology  clinical  trials  expertise  was 
also  included  for  these  specifications,  to  minimize 
disease-specific applicability. 
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Methods 
The  objective  of  this  study  was  to  define  the 
functional  requirements  for  a  Protocol  Lifecycle 
Tracking (PLT) tool.  While the activities of the trial 
initiation  phase  was  the  focus  for  this  requirement 
gathering, it is felt that the tool capabilities for this 
lifecycle phase will probably satisfy the needs of the 
subsequent trial conduct and closure phases, although 
this  cannot  be  said  with  certainty  until  these  later 
phases are further evaluated.  But for this study, the 
conduct and closure phases were out of scope. 
To  gather  the  functional  requirements  for  the  PLT 
tool  we  employed  use  case  systems  engineering 
methodology.
5  The  use  cases  describe  the  system 
processes and actors involved in the use of the PLT 
tool.  It should be noted that the use cases are for the 
PLT tool – not for the clinical trial initiation work 
flow that is being monitored by the PLT tool.  Thus 
the actors consist of clinical trial study personnel who 
use the PLT tool, including coordinators, managers, 
and PLT system administrators. 
Use  cases  can  vary  in  the  degree  of  detail  they 
capture.  Also the structural form of a use case can 
vary,  but  certain  elements  are  always  included.   
These  basic  use  case  elements  are  a  name,  brief 
description of the use case’s purpose, a summary, or 
“storyboard,”  giving  an  overview,  a  list  of  actors 
involved,  the  pre-condition  describing  the  system 
state required for the use case’s deployment, the flow 
of  events,  and  the  post-condition  describing  the 
system state after the completion of the use case. 
Use cases stipulate what a system must do, but not 
how it is to be done.  Software development teams 
can  use  the  use  cases  to  define  the  end  user 
functionality of the system they are coding, but they 
are free to employ whatever methods they choose to 
implement  that  functionality.    For  example,  the 
choice between employing thick or thin clients for an 
application would not be directed by the use cases.  
However  a  gray  area  in  this  distinction  between 
“what”  as  opposed  to  “how”  is  the  degree  of  user 
interface detail that should be included (if any) in use 
case definitions.  End users are more directly affected 
by  an  application’s  “user  friendliness”  than,  for 
instance, the choice of database deployment.  For our 
work with setting user functionality for the PLT tool 
we included user interface wireframes for this tool, as 
a  “picture”  that  expresses  a  thousand  words  in 
conveying the final overall functionality we want to 
obtain. 
Results 
Overview of the PLT tool 
The  Protocol  Lifecycle  Tracking  (PLT)  tool  is 
envisioned to be a standalone application that can be 
adopted by researchers to assist in the evolution of a 
protocol. The PLT will provide a view of data from 
disparate sources and will function as a dashboard to 
access real-time data on demand for those with the 
appropriate  access  privileges.  By  using  PLT,  the 
following innovative advantages could be realized: 
•  Ability  to  manage  the  process  flow  to  achieve 
compliance with associated timelines 
•  Documentation  of  the  lifecycle  of  a  protocol 
over its course. 
•  Ability to query status of protocol in real time. 
•  Visualization of the clinical trial process map for 
a specific site. 
•  Identify bottlenecks and/or redundant steps in the 
process. 
•  Allow  for  a  comparison  of  the  clinical  trial 
process between sites and sponsors. 
•  Transparency  of  the  clinical  trial  process 
between sites and sponsors. 
•  Enable  access  to  metrics  to  evaluate 
performance. 
•  Enable  automatic  notifications  and  alerts  to 
communicate  completion  status  of  essential 
milestones in the clinical trials process. 
 
The foundation of the PLT tool is a library populated 
with generic templates of  work flow Activities and 
Table 1. PLT tool terminology. 
Workflow 
Template 
A Workflow Template is a user defined plan with one or more activities that serve as the basis for creating a Study 
Workflow.  Templates serve as the starting point for creating a study-specific workflow which is applied to an actual 
clinical trial.  Multiple templates can be created to account for variances between different types of trials. 
Activity  An activity is a logical grouping of milestones that define a measurable amount of work or specific function.  For PLT 
purposes, an activity can contain any number of milestones, including no milestones.  In cases where an activity contains 
no milestones, the activity is in effect a milestone, but for the sake of consistency will still be defined as an activity.  
Activities are the building blocks for a Workflow Template. Only activities can be added to a template. 
Milestone  A milestone is an event that indicates the completion of a major deliverable.  Milestones are measurable and serve as 
progress markers, but by definition, are independent of time (meaning they have no duration), therefore no work or 
consumption of resources is associated with them.  Milestones are sub-events within an activity and must be associated 
with an activity. 
Dependency  A dependency is a relationship between activities or milestones.  Dependencies include activities/milestones that cannot be 
started until a previous activity/milestone has completed and/or a pre-defined amount of time has elapsed since the 
completion of an activity/milestone. 
Workflow 
Template 
Library 
The Workflow Template Library is the collection of all of the defined Workflow Templates as well as the defined 
Activities that can be associated with a Workflow Template. 
Study 
Workflow 
A study workflow is a template that has been applied to a specific actual study.  Once a template has been applied to a 
study, the Study Workflow becomes an independent entity distinct from the original template.  The Study Workflow can 
be modified to suit the particular study to which is was assigned; however, these changes will not reflect back on the 
original Workflow Template. 
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associated Milestones (see Table 1). For example, the 
activity  “IRB  Approval”  may  have  as  associated 
milestones  “Protocol  Submitted,”  “Protocol 
Reviewed,” “Protocol Conditionally Accepted,” and 
“Protocol  Approved.”    Each  template  can  have 
expected  normal  time  intervals  for  reaching  these 
milestones assigned so that the progress of a trial’s 
activities can be flagged as proceeding normally or as 
being delayed.  Activities and milestones can occur 
iteratively  (as  iterative  IRB  submissions  with 
modifications), and they can occur concurrently with 
other activities or be dependent upon the successful 
completion of another activity.  
These generic templates can be created with PLT for 
typical studies of different types (e.g., interventional 
cooperative  group  drug  study)  and  for  different 
perspectives  (coordinating  center  vs.  participating 
site).    These  templates  can  then  be  modified  as 
needed for application to managing the process flow 
and tracking the progress of a specific study. 
PLT tool Use Cases 
A total of 63 use cases were defined and documented 
for  the  PLT  tool  and  are  publicly  available.
6  The 
actors and use case names are summarized in Table 
2. 
Table 2.  Summary of PLT tool actors and use cases.             
Actors: 
   
  
   
 Select Workflow Template  
  system administrator 
   
  
   
 Apply Workflow Template to Study  
  coordinating center administrator 
 
  
   
 Modify Study Plan  
    participating site administrator 
 
  
   
 Set Triggered Alerts  
    clinical trials manager 
   
  
   
 Verify and Approve Study Plan  
  coordinator 
   
  
 
 Modify Study Plan  
    study team (e.g., data manager, protocol nurse)    
 
   Select Study Plan  
    Principal Investigator 
   
  
 
   Modify Study Plan  
         
   
  
 
   Modify Triggered Alerts  
  Use Cases: 
   
  
 
   Verify and Approve Study Plan  
 Manage Workflow Library 
   
  
 
 Stop Study Plan  
      Manage Activities  
   
  
 
   Select Study Plan  
       Add New Activity  
   
  
 
   Stop Study Plan  
         Create a New Activity  
 
  
 
   Re-start Study Plan  
         Set Default Activity Attributes  
 
  
 
 Import/Export Study Plans  
         Add/Modify Activity Milestone(s)  
 
    Manage Study Plan 
           Set Default Milestone Attributes  
 
  
 
 Update Study Plan  
         Set Default Milestone Dependencies            Select Study Plan  
         Verify and Approve Activity  
 
        Select Activity and Milestone  
     Retire Activity  
   
        Update Milestone Progress  
       Select Activity  
   
        Save Study Plan  
         Retire Activity  
   
      View Study Plan  
         Import/Export Activity Libraries  
 
        Select Study Plan  
    Manage Workflow Templates  
 
        View Study Plan  
        Add New Workflow Template  
 
      Subscribe to Triggered Alerts  
         Create a New Workflow Template  
 
        Select Study Plan  
         Add/Remove Activities from Workflow Template           Select Activity/Milestone  
         Add/Remove Milestones from Workflow Template          Subscribe to Activity/Milestone  
       Add Dependencies to Workflow Template           View Dashboard  
         Verify and Approve Workflow Template       Manage Portfolio  
         Retire Workflow Template  
 
        View Metrics  
         Select Workflow Template  
 
        View Reports  
         Retire Workflow Template  
 
    Administer System   
       Import/Export Workflow Template  
 
        Manage User Access  
  Manage Study Plan Library 
   
    
 
 Manage Study Roles  
     Create Study Plan  
   
    
 
 Manage Email Templates  
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Discussion 
The complexity of protocol activities and milestones 
– that they may occur iteratively, or that they may 
occur  concurrently  or  be  dependent  on  successful 
completion of another, or that their occurrence at all 
depends on the trial’s sponsor – is managed primarily 
in the use cases “set default milestone attributes” and 
“set default milestone dependencies” as well as in the 
tool’s overall ability to have different templates and 
study plans for different protocols (e.g., cooperative 
group  drug  studies  vs.  investigator  initiated  non-
interventional trial).  The need for this flexibility is 
apparent if one considers a typical protocol initiation 
work flow as summarized in Figure 1. This schematic 
focusing on study initiation shows the different paths 
and  activities  necessitated  for  pharmaceutical 
industry  trials,  and  the  iterative  nature  of  some 
processes.  It should be kept in mind that this work 
flow is from the perspective of a participating site – a 
coordinating site would have a different work flow 
for activating the same protocol. 
A very significant benefit of using this tool will be 
the ability to manage the process workflow so that 
the  clinical  research  staff  know  what  activities  are 
required,  and  when  they  are  to  be  performed.  
Furthermore, delays in the anticipated schedule can 
be detected quickly and interventions undertaken to 
prevent a trial initiation from becoming “stuck.” 
As mentioned above, non-cancer clinical trial work 
flows were also considered.  While work flow details 
may  differ,  no  disease-specific  PLT  requirements 
were encountered. 
As had been stated in the Methods section, use case 
analysis  is  focused  on  the  “what”  rather  than  the 
“how.”  While user interface specification in a sense 
crosses  this  boundary,  several  wireframes  were 
prepared  for  our  study  of  PLT  tool  use  cases  to 
convey the overall “look and feel” being sought.  A 
wireframe of a possible dashboard for a clinical trials 
manager, showing a summary of the status of all trial 
either “in the pipeline” or currently open is shown in 
Figure 2.  Using colors such as green and red for the 
circles in the two columns after each milestone listing 
would  immediately  convey  whether  the  milestone 
had exceeded its anticipated completion time or not.   
Conclusion 
These  use  cases  have  been  made  available  to  the 
public as noted in the Reference section.  They have 
also been presented to the caBIG
® CTMS work space 
community and discussed at its meetings.  The next 
step will be for  software developers to write code for 
an application that satisfies these use cases. 
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Figure 1. Typical work flow requiring PLT tool representation. 
Figure 2.  Dashboard wireframe for a trials manager showing the status of various protocols. 
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